Impax Laboratories Announces Settlement of Litigation Relating to Concerta

Impax Laboratories announced that it and Teva Pharmaceuticals have reached agreement with Janssen Pharmaceuticals and ALZA to settle pending U.S. litigation with regard to the production and sale of generic formulations of Concerta (methylphenidate hydrochloride extended release tablets, 18 mg, 27 mg, 36 mg and 54 mg).
Equities